Fig. 4From: NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarkerCorrelation between expression of selected miRNAs and SLE clinical characteristics. a ROC curve analysis of NovelmiRNA-25 and miR-1273h-5p expression in patients with SLE. b Expression of NovelmiRNA-25 and miR-1273h-5p in active group and stable groupBack to article page